Taken together, these findings provide evidence that breast cancer cells harbouring single allele ER-Y537S mutations acquire both a resistance to anti-estrogens and a capacity to grow efficiently under estrogen-depleted conditions. Here, ESR1 is linked to breast carcinoma.